48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2011

Study Completion Date

July 31, 2013

Conditions
Infection, Human Immunodeficiency Virus I
Interventions
DRUG

LEXIVA (GW433908)

Fosamprenavir suspension or tablet bid

DRUG

Ritonavir

Ritonavir solution bid

Trial Locations (39)

2013

GSK Investigational Site, Soweto

2020

GSK Investigational Site, Antwerp

2112

GSK Investigational Site, Coronationville

4013

GSK Investigational Site, Durban

7505

GSK Investigational Site, Parow Valley

10016

GSK Investigational Site, New York

10021

GSK Investigational Site, New York

10037

GSK Investigational Site, New York

10457

GSK Investigational Site, The Bronx

11042

GSK Investigational Site, New Hyde Park

19134

GSK Investigational Site, Philadelphia

27710

GSK Investigational Site, Durham

28041

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

29010

GSK Investigational Site, Málaga

32209

GSK Investigational Site, Jacksonville

33606

GSK Investigational Site, Tampa

35233

GSK Investigational Site, Birmingham

36204

GSK Investigational Site, Vigo ( Pontevedra)

41013

GSK Investigational Site, Seville

46009

GSK Investigational Site, Valencia

75235

GSK Investigational Site, Dallas

76104

GSK Investigational Site, Fort Worth

90033

GSK Investigational Site, Los Angeles

94609

GSK Investigational Site, Oakland

105275

GSK Investigational Site, Moscow

129110

GSK Investigational Site, Moscow

196645

GSK Investigational Site, Saint Petersburg

02115-5724

GSK Investigational Site, Boston

02118

GSK Investigational Site, Boston

V6H 3N1

GSK Investigational Site, Vancouver

R3E 3P4

GSK Investigational Site, Winnipeg

M5G 1X8

GSK Investigational Site, Toronto

H3T 1C5

GSK Investigational Site, Montreal

021105

GSK Investigational Site, Bucharest

030303

GSK Investigational Site, Bucharest

08003

GSK Investigational Site, Barcelona

08950

GSK Investigational Site, Barcelona

07014

GSK Investigational Site, Palma de Mallorca

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY

NCT00089583 - 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection | Biotech Hunter | Biotech Hunter